BROOKS PETER C has a total of 11 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are STEALTH BIOTHERAPEUTICS CORP, AMYLIN CORP and RHYTHM PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Brooks Peter C | 11 |
#2 | Akalu Abebe | 4 |
#3 | Liebes Leonard | 4 |
#4 | Policarpio Desiree | 3 |
#5 | Cretu Alexandra | 3 |
#6 | Roth Jennifer M | 2 |
#7 | Rodriguez Dorothy | 2 |
#8 | Morais Danielle | 2 |
#9 | Canary James | 1 |
#10 | Kramer Elissa | 1 |
Publication | Filing date | Title |
---|---|---|
US2012203051A1 | Treatment of cancer using the sodium salt of a benzoic acid derivative | |
US2006240002A1 | Methods of inhibiting angiogenesis-dependent conditions mediated by cryptic epitopes of extracellular matrix components | |
US2006216236A1 | Methods of inhibiting alphavBeta3-mediated angiogenesis and tumor development | |
US2006216237A1 | Inhibition of angiogenesis and tumor development by IGFBP-4 | |
US2005209334A1 | Treatment of cancer using benzoic acid derivatives |